Energenesis Biomedical Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Energenesis Biomedical Co Ltd

Watchlist Manager

Watchlist

Price: 35.4 TWD -0.84% Market Closed

Market Cap: NT$3.1B

E	Energenesis Biomedical Co Ltd TWSE:6657	TW
	Doxee SpA MIL:DOX	IT

Profitability Summary

Energenesis Biomedical Co Ltd's profitability score is 15/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

76%

Strong 3Y Average Gross Margin

74%

Gross Margin is Increasing

71% > 76%

Negative Operating Margin

-3 587%

Negative 3Y Average Operating Margin

-3 648%

Operating Margin is Increasing

-4 079% > -3 587%

Negative Net Margin

-3 367%

Negative 3Y Average Net Margin

-3 476%

Net Margin is Increasing

-4 018% > -3 367%

Negative Free Cash Flow Margin

-2 928%

Negative 3Y Average Free Cash Flow Margin

-3 165%

Free Cash Flow Margin is Increasing

-3 843% > -2 928%

Negative ROE

-32%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-214%

Declining ROIC

-226% > -243%

View All

Hide

Collapse

15 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.